Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
41.18
-0.48 (-1.15%)
At close: Jun 18, 2025, 4:00 PM
43.06
+1.88 (4.57%)
After-hours: Jun 18, 2025, 4:55 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.40 billion as of June 18, 2025. Its market cap has decreased by -7.16% in one year.
Market Cap
2.40B
Enterprise Value
1.73B
1-Year Change
-7.16%
Ranking
Category
Stock Price
$41.18
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.40B, an increase of 197.15%. That is a compound annual growth rate of 75.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 2.40B | -6.75% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 710.32B |
| Johnson & Johnson | 366.64B |
| Novo Nordisk | 334.60B |
| AbbVie | 327.63B |
| UnitedHealth Group | 280.19B |
| Abbott Laboratories | 230.15B |
| Novartis AG | 229.92B |
| AstraZeneca | 223.18B |